Results 241 to 250 of about 66,190,054 (394)
Open-Source System Suitability: Mass Spectrometry Query Language Lab (MassQLab). [PDF]
Rapid Commun Mass SpectromWinter HL, Johnson D, Jarmusch AK.
europepmc +1 more source
LINKAGE DATA FOR GROUP III MARKERS IN NEUROSPORA [PDF]
, 1959 David D. Perkins, Chiyoko Ishitani
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Dextran vs. Crystalloid Priming Solution in Cardiac Surgery: A Randomized Trial on Acute Kidney Injury. [PDF]
Acta Anaesthesiol ScandJuvakka O +5 more
europepmc +1 more source
Standard Values in Blood: Being the First Fascicle of a Handbook of Biological Data [PDF]
, 1953 Errett C. Albritton
openalex +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
Assessment of Deep Convolutional Neural Network Models for the Classification of Benign Fibro-Osseous Lesions of the Jaws. [PDF]
Clin Exp Dent ResAchararit P +5 more
europepmc +1 more source